140 related articles for article (PubMed ID: 2739074)
1. [Clinical evaluation of radioimmunoscintigraphy using a I-131 anti CEA and CA 19-9 monoclonal antibodies cocktail (IMACIS-1)].
Takahashi T; Tsujino D; Kato Y; Wada Y; Someya K; Itagaki K; Imanishi Y; Ishikawa T; Sakaki T; Sasaki Y
Gan No Rinsho; 1989 Jun; 35(7):828-33. PubMed ID: 2739074
[TBL] [Abstract][Full Text] [Related]
2. [Clinical evaluation of immunoscintigraphy with 131I anti-CEA and 131I anti-CA 19-9 monoclonal antibody cocktail (IMACIS-1)--report of the phase II study].
Sasaki Y; Inoue T; Oriuchi N; Mitsuhashi N; Nagai T; Igarashi H; Tsujino D; Takahashi T; Sakaki T; Okazaki A
Kaku Igaku; 1990 Apr; 27(4):349-62. PubMed ID: 2198368
[TBL] [Abstract][Full Text] [Related]
3. [Experimental study of tumor detection using 131I-labeled F (ab)2 fragments of monoclonal antibodies to CA 19-9 and CEA (IMACIS-1)].
Mitsuhashi N; Kazumoto T; Nakayama Y; Sugiyama S; Yamakawa M; Yonome I; Nakamura Y; Nagai T; Niibe H
Gan No Rinsho; 1989 Dec; 35(15):1753-8. PubMed ID: 2691716
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis using monoclonal antibody imaging in the clinical follow-up of colorectal cancer].
Campos Villarino LM; Pajares Vinardell M; Freire Macias JM; Vale Gonsalves EI; Millán Núñez-Cortés J; Senra Varela A
An Med Interna; 1991 Aug; 8(8):377-81. PubMed ID: 1768746
[TBL] [Abstract][Full Text] [Related]
5. [A fundamental study of immunoscintigraphy with 131I-labeled anti-CA 19-9 and anti-CEA monoclonal antibodies--imaging of tumor-bearing mice by IMACIS-1 and cell ELISA with human tumor cells].
Nogami T; Miura H; Ohmi S; Kazahaya Y
Kaku Igaku; 1990 May; 27(5):427-36. PubMed ID: 2395226
[TBL] [Abstract][Full Text] [Related]
6. Radioimmunoscintigraphy using monoclonal antibodies to CEA, CA 19-9 and CA 125.
Baum RP; Lorenz M; Hottenrott C; Albrecht M; Senekowitsch R; Happ J; Hertel A; Spitz J; Hör G
Int J Biol Markers; 1988; 3(3):177-84. PubMed ID: 3230337
[TBL] [Abstract][Full Text] [Related]
7. Imaging of pancreatic and colorectal cancer using antibody fragments: a preliminary evaluation.
Ballantyne KC; Perkins AC; Selby C; Wastie ML; Hardcastle JD
Eur J Surg Oncol; 1988 Oct; 14(5):393-8. PubMed ID: 3181442
[TBL] [Abstract][Full Text] [Related]
8. Intraoperative radioimmunolocalization of an anti-CEA MAb F(Ab')2 (FO23C5) in CEA serum-negative colorectal cancer patients.
Roselli M; Guadagni F; Buonomo O; Belardi A; Vittorini V; Cavazzana A; Spagnoli LG; Cipriani C; Casciani CU
Anticancer Res; 1996; 16(2):883-9. PubMed ID: 8687145
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunodetection of cancer of gastrointestinal tract and liver metastasis with I-131 anti-CEA and I-131 anti-CA19-9 monoclonal antibody cocktail (IMACIS-1).
Naruki Y; Urita Y; Miyachi Y; Otsuka S; Noguchi M; Kogure T; Sasaki Y
Ann Nucl Med; 1994 Aug; 8(3):163-9. PubMed ID: 7811557
[TBL] [Abstract][Full Text] [Related]
10. Radioimmunoscintigraphy using iodine-131-anti-CEA monoclonal antibodies and thallium-201 scintigraphy in medullary thyroid carcinoma: a case report.
Zanin DE; van Dongen A; Hoefnagel CA; Bruning PF
J Nucl Med; 1990 Nov; 31(11):1854-5. PubMed ID: 2231001
[TBL] [Abstract][Full Text] [Related]
11. [Clinical application of radioimmunolocalization in colorectal cancer].
Germà JR; Alvarez I; Carrió I; Estorch M; Bernà L; Martínez-Duncker C; Marcuello E; Nogueras FM
Med Clin (Barc); 1990 Mar; 94(9):325-8. PubMed ID: 2329866
[TBL] [Abstract][Full Text] [Related]
12. [Scintigraphic detection of malignancies with radioactively labelled tumor antibodies. Clinical results based on immunohistochemical research].
Biersack HJ; Bockisch A; Vogel J; Oehr P; Hansen HH; Hartlapp J; Biltz H; Jaeger N; Bellmann O
Dtsch Med Wochenschr; 1987 Feb; 112(9):341-4. PubMed ID: 2434296
[TBL] [Abstract][Full Text] [Related]
13. A new biomarker in monitoring breast cancer: CA 549.
Beveridge RA; Chan DW; Bruzek D; Damron D; Bray KR; Gaur PK; Ettinger DS; Rock RC; Shurbaji MS; Kuhajda FP
J Clin Oncol; 1988 Dec; 6(12):1815-21. PubMed ID: 3058875
[TBL] [Abstract][Full Text] [Related]
14. Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids.
Sutherland R; Buchegger F; Schreyer M; Vacca A; Mach JP
Cancer Res; 1987 Mar; 47(6):1627-33. PubMed ID: 3545451
[TBL] [Abstract][Full Text] [Related]
15. Metastatic colorectal cancer: radioimmunoscintigraphy with a stabilized In-111-labeled F(ab')2 fragment of an anti-CEA monoclonal antibody.
Lamki LM; Patt YZ; Rosenblum MG; Shanken LJ; Thompson LB; Schweighardt SA; Frincke JM; Murray JL
Radiology; 1990 Jan; 174(1):147-51. PubMed ID: 2294542
[TBL] [Abstract][Full Text] [Related]
16. Tumour markers in colorectal cancer.
Roberts PJ
Scand J Gastroenterol Suppl; 1988; 149():50-8. PubMed ID: 3201159
[TBL] [Abstract][Full Text] [Related]
17. [Anti-CEA immunoscintigraphy in postoperative follow-up of tumor patients. Differentiated use of various monoclonal antibody preparations].
Leitha T; Baur M; Steger G; Dudczak R
Wien Klin Wochenschr; 1990 Sep; 102(17):503-9. PubMed ID: 2264338
[TBL] [Abstract][Full Text] [Related]
18. Current status of immunoscintigraphy in colorectal cancer--results of 5 years' clinical experiences.
Hölting T; Schlag P; Georgi P
Eur J Surg Oncol; 1990 Aug; 16(4):312-8. PubMed ID: 2199223
[TBL] [Abstract][Full Text] [Related]
19. [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis].
Lorenz M; Happ J; Hottenrott C; Maul FD; Baum RP; Hör G; Encke A
Nuklearmedizin; 1986 Feb; 25(1):9-14. PubMed ID: 3459133
[TBL] [Abstract][Full Text] [Related]
20. [The value of tumor markers CA 15-3 and CEA in breast cancer].
Buck I; Lindner C; Böge K; Kitschke HJ
Arch Gynecol Obstet; 1989; 245(1-4):674-7. PubMed ID: 2802753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
